Id Biomedical Corporation

Id Biomedical Corporation of Quebec

Stephane Rioux

Bernard R Brodeur

Denis Martin

Josee Hamel

Patrick Rheault

Martine Boyer

Josée Hamel

The present invention relates to antigens more particularly antigens of(also called group A(GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.

Streptococcus pyogenes antigens and corresponding DNA fragments

The present invention relates to antigens, more particularly antigenS of(also called group A(GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.

[object Object]

The present invention relates to antigens, more particularly antigens of(also called group A(GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.

The present invention relates to antigens, more particularly antigens of(also called group A(GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.

The present invention relates to antigens, more particularly an antigen of(also called group A(GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.

The present invention relates to antigens, more particularly antigens of(also called group A(GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis. 

Group Bpolypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.

Growing community of inventors

Beauport, Canada

Stephane Rioux